نتایج جستجو برای: anti tetanus antibody

تعداد نتایج: 483861  

Journal: :Infection and immunity 1998
R Dagan J Eskola C Leclerc O Leroy

The plethora of newly discovered vaccines implies that, in the future, many vaccines will have to be administered simultaneously to infants. We examined the potential interference with the immune response of several coadministered vaccines containing the same protein component, namely, tetanus toxoid (TT). Infants simultaneously receiving a tetravalent pneumococcal vaccine conjugated to TT (Pnc...

2013
Christine Jones Louisa Pollock Sara M Barnett Anna Battersby Beate Kampmann

OBJECTIVES To determine maternal and neonatal specific antibody levels to selected vaccine-preventable infections (pertussis, Haemophilus influenzae type b (Hib), tetanus and pneumococcus). DESIGN Prospective cohort study. SETTING A UK secondary care maternity unit (March 2011-January 2012). PARTICIPANTS Mothers and infants within 72 h of delivery were eligible. Unwell individuals, mother...

Journal: :Klimik Dergisi 2022

Objective: Our country has limited data on protective antibody levels following primary tetanus immunization. In this study, we planned to evaluate the seroprevalence of healthcare workers in our hospital according age and occupational groups. Methods: Tetanus were determined by enzyme-linked immunosorbent assay (ELISA) method. Antibody results obtained through operating system, level ≥0.5 IU/m...

Journal: :Infection and immunity 1999
S J Ward G Douce D Figueiredo G Dougan B W Wren

The C-terminal repeat domain of Clostridium difficile toxin A harbors toxin-neutralizing epitopes and is considered to be a candidate component of a vaccine against C. difficile-associated disease (CDAD). Fourteen of the 38 C-terminal toxin A repeats (14CDTA) were cloned into pTECH-1 in frame with the immunogenic fragment C of tetanus toxin (TETC) to generate plasmid p56TETC. Expression of the ...

Journal: :PLoS ONE 2008
Caterina Hatzifoti Andrew Bacon Helen Marriott Peter Laing Andrew W. Heath

BACKGROUND Antibody against CD40 is effective in enhancing immune responses to vaccines when chemically conjugated to the vaccine antigen. Unfortunately the requirement for chemical conjugation presents some difficulties in vaccine production and quality control which are compounded when multivalent vaccines are required. We explore here an alternative to chemical conjugation, involving the co-...

Journal: :iranian journal of pathology 2012
ali eslamifar amitis ramezani mohammad banifazl arezoo aghakhani

background and objectives: hiv infected patients are at risk for vaccine-preventable infections such as tetanus and diphtheria (td). in these patients, these antibodies tend to decline faster. due to the limited data, this study assessed the seroprevalence of tetanus and diphtheria antibodies in hiv infected patients in tehran, iran. materials and methods: this case-control study was carried o...

Journal: :Infection and immunity 1999
G M Glenn T Scharton-Kersten R Vassell G R Matyas C R Alving

Transcutaneous immunization (TCI) is a new technique that uses the application of vaccine antigens in a solution on the skin to induce potent antibody responses without systemic or local toxicity. We have previously shown that cholera toxin (CT), a potent adjuvant for oral and nasal immunization, can induce both serum and mucosal immunoglobulin G (IgG) and IgA and protect against toxin-mediated...

Journal: :The Journal of clinical investigation 1979
A B Gottlieb R G Lahita N Chiorazzi H G Kunkel

Peripheral blood mononuclear cells from 46 systemic lupus erythematosus (SLE) patients showed reduced ability to proliferate in vitro in response to the soluble antigen, tetanus toxoid, as compared with 96 normal controls. Special studies of 27 untreated SLE patients also revealed significantly decreased blastogenic responses to tetanus toxoid. In both the total and untreated SLE populations, d...

Journal: :Journal of accident & emergency medicine 1996
P M Reid D Brown N Coni A Sama M Waters

OBJECTIVE To emphasise that tetanus still occurs in the United Kingdom, particularly in elderly people-as illustrated by two case reports-and to examine the state of tetanus immunity in elderly people. METHODS 111 elderly people (over 65 years) were studied: 43 males, mean age 77.7 years, range 67-94; 68 females, mean age 81.3 years, range 67-95. They were either attending the accident servic...

Journal: :Vaccine 1999
R Zurbriggen R Glück

The immunogenicity and protectivity of two different toxoid vaccines were compared in mice. In one formulation, toxoids (diphtheria or tetanus) were adsorbed to alumoxid, whereas in the other formulation the toxoids were crosslinked to immunopotentiating reconstituted influenza virosomes (IRIVs). A preimmunization with influenza antigens is necessary for a good anti-toxoid antibody response whe...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید